Verastem Oncology
VSTM
$10.90
Share price
5.21%
Change (1 day)
2,322.22%
Change (1 year)
Categories
Verastem Oncology (VSTM) - Cash on Hand
Cash on Hand as of December 2023 : $0.13 B
According to Verastem Oncology
's latest financial reports the company has $0.13 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Verastem Oncology - Cash on Hand chart (from 2011 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $87.89 M | -12.33% |
| 2021-12-31 | $0.10 B | -29.01% |
| 2020-12-31 | $0.14 B | 87.04% |
| 2019-12-31 | $75.5 M | -69.76% |
| 2018-12-31 | $0.24 B | 188.04% |
| 2017-12-31 | $86.67 M | 7.14% |
| 2016-12-31 | $80.89 M | -26.63% |
| 2015-12-31 | $0.11 B | 18.97% |
| 2014-12-31 | $92.67 M | -8.53% |
| 2013-12-31 | $0.10 B | 79.07% |
| 2012-12-31 | $56.57 M | 18.33% |
| 2011-12-31 | $47.81 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 9,154.06% | 🇺🇸 USA |
 LabCorp LH | $0.53 B | 291.46% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | 4,534.19% | 🇬🇧 UK |
 Curis CRIS | $56.33 M | -58.92% | 🇺🇸 USA |